Literature DB >> 29940343

Comparison of different cytotoxicity assays for in vitro evaluation of mesoporous silica nanoparticles.

Katharina Braun1, Christina Martina Stürzel2, Johannes Biskupek3, Ute Kaiser4, Frank Kirchhoff5, Mika Lindén6.   

Abstract

Colorimetric or luminogenic cytotoxicity assays are typically applied for in vitro cytotoxicity evaluations due to their easy handling and low cost. However, the results may be strongly assay-dependent. Furthermore, when applied to nanoparticle toxicity screening, nanoparticle-specific interferences can occur. Therefore, it is important to evaluate the assays for different classes of nanoparticles. Mesoporous silica nanoparticles (MSNs) have emerged as a promising platform for both diagnostic and therapeutic applications but a comparison between the commonly employed colorimetric formazan-dependent MTT and WST-1 and luminescent ATP-dependent cytotoxicity assays is still missing. In this work, we evaluated the applicability of four different in vitro cell viability assays for the cytotoxicity analysis of three differently functionalized mesoporous silica nanoparticles towards TZM-bl indicator cells. The results derived from the colorimetric measurements of cell-viability were compared with results obtained by cell count experiments, flow cytometry, and optical microscopy. The correlation between the viability assay results and the viable cell count was observed to be both assay and particle dependent. The MTT assay generally overestimated the cytotoxicity of the mesoporous silica particles, while the WST-1 assay sometimes clearly underestimated their cytotoxicity and even suggested a viability exceeding 100%. Of the two ATP-based assays, the CellTiterGlo assay gave the best correlation with cell count data, although some particle-dependent effects were observed. In conclusion, ATP-based assays seem most suitable for in vitro cytotoxicity evaluation of MSNs.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell count; Cytotoxicity assays; Mesoporous silica nanoparticles; Surface functionalization

Mesh:

Substances:

Year:  2018        PMID: 29940343     DOI: 10.1016/j.tiv.2018.06.019

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  7 in total

1.  Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems.

Authors:  Yi Wei; Bastian Amend; Tilman Todenhöfer; Nizar Lipke; Wilhelm K Aicher; Falko Fend; Arnulf Stenzl; Niklas Harland
Journal:  Int J Mol Sci       Date:  2022-06-04       Impact factor: 6.208

2.  Influence of Critical Parameters on Cytotoxicity Induced by Mesoporous Silica Nanoparticles.

Authors:  Amirsadra Ahmadi; Moses Sokunbi; Trisha Patel; Ming-Wei Chang; Zeeshan Ahmad; Neenu Singh
Journal:  Nanomaterials (Basel)       Date:  2022-06-11       Impact factor: 5.719

3.  Evaluation of a new lymphocyte proliferation assay based on cyclic voltammetry; an alternative method.

Authors:  Mohammad Nikbakht; Babak Pakbin; Gholamreza Nikbakht Brujeni
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

Review 4.  Bare Iron Oxide Nanoparticles: Surface Tunability for Biomedical, Sensing and Environmental Applications.

Authors:  Massimiliano Magro; Fabio Vianello
Journal:  Nanomaterials (Basel)       Date:  2019-11-12       Impact factor: 5.076

5.  Interaction of Ras Binding Domain (RBD) by chemotherapeutic zinc oxide nanoparticles: Progress towards RAS pathway protein interference.

Authors:  Elza Neelima Mathew; Miranda N Hurst; Baolin Wang; Vaibhav Murthy; Yuntao Zhang; Robert K DeLong
Journal:  PLoS One       Date:  2020-12-16       Impact factor: 3.240

6.  Bacterial exposure leads to variable mortality but not a measurable increase in surface antimicrobials across ant species.

Authors:  Omar Halawani; Robert R Dunn; Amy M Grunden; Adrian A Smith
Journal:  PeerJ       Date:  2020-12-03       Impact factor: 2.984

Review 7.  Nanotechnology-Based Strategies to Develop New Anticancer Therapies.

Authors:  Massimiliano Magro; Andrea Venerando; Alberto Macone; Gianluca Canettieri; Enzo Agostinelli; Fabio Vianello
Journal:  Biomolecules       Date:  2020-05-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.